Patient Preferences: The Third Pillar in CLL Treatment Decisions

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ERIC 2022 - European Research Initiative on CLL - ERIC

http://www.ericll.org/

Videos

Playback speed

10 seconds

Patient Preferences: The Third Pillar in CLL Treatment Decisions

By ERIC 2022 - European Research Initiative on CLL - ERIC FEATURING Christina Karamanidou

14 views

November 8, 2022

Comments 0

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Videos

My Vision of the Future of CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

K. Rai

97 views

Outcomes of Patients With CLL and COVID-19 Infection

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Chatzikonstantinou

77 views

Outcomes of SARS-CoV-2 Vaccination in Patients with CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

Y. Herishanu

44 views

Practical Considerations on COVID-19 Management in Patients With CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

A. Cuneo

19 views

The CLL Microenvironment

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Hartmann

38 views

Cellular Therapies in CLL: Present and Future

ERIC 2022 - European Research Initiative on CLL - ERIC

M. Ruella

25 views

Round Table Discussion: Optimizing Treatment Outcomes in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

C. Moreno, B. Eichhorst, J. Seymour, A. Kater, T. Kipps

29 views

The Molecular Basis of Resistance to Treatment in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

T. Zenz

58 views

From Bench to Bedside: Targeting Signalling Pathways in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

J. Brown

16 views

From Bench to Bedside: Targeting Apoptosis in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

J. Seymour

16 views

Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

P. Hillmen

47 views

A Multi-Omics Perspective to the Origin, Nature, and Evolution of CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

J. Ignacio Martín-Subero

9 views

The Tumor: Biomarker-Guided Treatment in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

O. Al-Sawaf

148 views

The Host: Focus on Frailty Assessment in CLL

ERIC 2022 - European Research Initiative on CLL - ERIC

L. Smolej

19 views